Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | 23 | 0 | 6 | 0 | €65.50 | €79.43 | 21.267% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €59.50 | €83.81 | 40.865% |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.05 | €28.06 | 86.426% |
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.58 | €11.05 | 208.615% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.70 | - | - |
| Krystal Biotech | 16 | 0 | 3 | 0 | €146.15 | €173.22 | 18.521% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.14 | €10.05 | 143.085% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €40.60 | €46.19 | 13.756% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €12.16 | €28.17 | 131.642% |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.93 | €8.39 | 335.308% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.06 | €38.19 | 100.386% |
| Insmed Inc. | 13 | 1 | 2 | 1 | €23.60 | €44.01 | 86.469% |
| Intellia Therapeutics Inc | 12 | 0 | 0 | 0 | €22.00 | €60.13 | 173.295% |
| Prothena Corp. plc | 12 | 0 | 1 | 0 | €21.40 | €81.43 | 280.523% |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.49 | €4.63 | 32.735% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €22.60 | €35.43 | 56.767% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.00 | €23.46 | 67.599% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €11.00 | €27.03 | 145.736% |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.11 | €13.74 | 1136.922% |
| Heron Therapeutics Inc. | 9 | 1 | 4 | 0 | €2.42 | €4.57 | 89.000% |
| Biocryst Pharmaceuticals | 8 | 0 | 1 | 0 | €4.97 | €10.96 | 120.491% |
| WAVE Life Sciences Ltd | 8 | 0 | 0 | 0 | €5.75 | €9.10 | 58.275% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €3.50 | €5.76 | 64.469% |